| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.37 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.23 | 0.08 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |